Drug Name: | Ampicillin (69-53-4) |
---|---|
PubChem ID: | 6249 |
SMILES: | CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)C |
InchiKey: | AVKUERGKIZMTKX-NJBDSQKTSA-N |
Therapeutic Category: | Anti-Bacterial Agents, Anti-Infective Agents |
Molecular Weight (dalton) | : | 349.412 |
LogP | : | 0.3181 |
Ring Count | : | 1 |
Hydrogen Bond Acceptor Count | : | 5 |
Hydrogen Bond Donor Count | : | 3 |
Total Polar Surface Area | : | 112.73 |
This panel provides information on interacting drugs and their ADRs along with references
Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
---|---|---|---|---|
Chloramphenicol (56-75-7) | Bacterial Meningitis | Antagonistic | By no means fully understood | Antibiotic antagonism in bacterial meningitis |
Allopurinol (315-30-0) | Skin rash | Additive | Not understood. One suggestion is that the hyperuricaemia was responsible. Another is that hyperuricaemic individuals may possibly have an altered immunological reactivity | Excess of ampicillin rashes associated with allopurinol or hyperuricemia A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center |
This panel provides drug-protein interaction and their ADRs along with references
Toxicity | Interacting Protein | Mechanism | Reference |
---|
This panel provides drug-food interactions and their ADRs along with references
Food | Toxicity | Reference |
---|
This panel provides information on metabolites and their ADRs along with references
Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
---|
This panel provides information on drug category